ALFA Filings
Every announcement, straight from the exchange
Every IOL Chemicals and Pharmaceuticals other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
7 announcements with these filters
The company submitted its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
IOL Chemicals and Pharmaceuticals Limited informed the Exchange about the dispatch of reminder letters to shareholders holding physical shares for updating their KYC details.
IOL Chemicals and Pharmaceuticals Limited has submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year 2025-26 in compliance with SEBI regulations.
IOL Chemicals is reminding shareholders to claim unclaimed dividends and update KYC to avoid IEPF transfer. This is a routine compliance communication with no material financial impact.
IOL Chemicals submitted its Annual Secretarial Compliance Report for FY2026. The report notes minor regulatory fines paid for a filing delay and past board vacancy.
IOL Chemicals and Pharmaceuticals Limited submitted its compliance certificate for the quarter ended March 31, 2026, regarding the Structured Digital Database. The company confirmed it maintains an audit-trail enabled, non-tamperable database for UPSI as per SEBI (Prohibition of Insider Trading) Regulations. No non-compliances were reported for the period.
IOL Chemicals and Pharmaceuticals Ltd submitted a compliance certificate for the quarter ended March 31, 2026. The certificate confirms that physical share certificates received for dematerialisation were processed, cancelled, and substituted with the depository's name in the company's records.